BDBM472954 (R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-pyrazino[1,2-a][1,8]naphthyridine::US10836764, Compound 119

SMILES COCc1ccnc2N3CCNC[C@H]3CCc12

InChI Key InChIKey=JZNPRZRCDYEBIG-UHFFFAOYSA-N

Data  6 KI  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 472954   

Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataEC50:  5nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  10nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  10.5nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  100nMAssay Description:Displacement of [3H]-DOI from recombinant human 5HT2AR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  106nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  126nMAssay Description:Displacement of [3H]-LSB from recombinant human 5HT2BR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataKi:  138nMAssay Description:Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataEC50:  794nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed